Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis

Detalhes bibliográficos
Autor(a) principal: Silva, Leandro B. R.
Data de Publicação: 2017
Outros Autores: Dias, Lucas S., Rittner, Glauce M. G., Munoz, Julian E., Souza, Ana C. O., Nosanchuk, Joshua D., Travassos, Luiz R. [UNIFESP], Taborda, Carlos P.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.3389/fmicb.2017.01057
https://repositorio.unifesp.br/handle/11600/53657
Resumo: Paracoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, with the highest prevalence in Brazil, Colombia, and Venezuela. Fungi of the Paracoccidioides genus are etiologic agents of the disease. The 15 amino acid peptide P10 is derived from gp43, the main diagnostic antigen of Paracoccidioides brasiliensis. We previously reported that P10-pulsed dendritic cells (DCs) induce a protective response against P. brasiliensis. Presently, dexamethasone-treated BALB/c mice were intratracheally infected with P. brasiliensis Pb18 to establish the therapeutic efficacy of P10-pulsed DCs. Immunosuppressed and infected animals that received DCs had a reduction in their fungal burden, and this result was most pronounced in mice receiving DCs primed with P10. The efficacy of therapeutic DCs was significantly augmented by concomitant treatment with trimethoprim-sulfamethoxazole. Additionally, primedDCs with or without the antifungal drug induced a beneficial Th1-biased immune response and significantly reduced tissue damage. In conclusion, these studies with immunocompromised mice demonstrate that P10-pulsed DCs with or without concomitant antifungal drugs are potently effective in combating invasive PCM. These findings support further translational studies to validate the use of P10-primed DCs for PCM in immunocompetent and immunosuppressed hosts.
id UFSP_a0faab0b46ab028394a4a4d1cb1ee89e
oai_identifier_str oai:repositorio.unifesp.br/:11600/53657
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with ParacoccidioidomycosisParacoccidioides brasiliensisparacoccidioidomycosisP10adjuvantsdendritic cellsvaccineParacoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, with the highest prevalence in Brazil, Colombia, and Venezuela. Fungi of the Paracoccidioides genus are etiologic agents of the disease. The 15 amino acid peptide P10 is derived from gp43, the main diagnostic antigen of Paracoccidioides brasiliensis. We previously reported that P10-pulsed dendritic cells (DCs) induce a protective response against P. brasiliensis. Presently, dexamethasone-treated BALB/c mice were intratracheally infected with P. brasiliensis Pb18 to establish the therapeutic efficacy of P10-pulsed DCs. Immunosuppressed and infected animals that received DCs had a reduction in their fungal burden, and this result was most pronounced in mice receiving DCs primed with P10. The efficacy of therapeutic DCs was significantly augmented by concomitant treatment with trimethoprim-sulfamethoxazole. Additionally, primedDCs with or without the antifungal drug induced a beneficial Th1-biased immune response and significantly reduced tissue damage. In conclusion, these studies with immunocompromised mice demonstrate that P10-pulsed DCs with or without concomitant antifungal drugs are potently effective in combating invasive PCM. These findings support further translational studies to validate the use of P10-primed DCs for PCM in immunocompetent and immunosuppressed hosts.Univ Sao Paulo, Trop Med Inst USP LIM53, Lab Med Mycol, Sao Paulo, BrazilUniv Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, BrazilAlbert Einstein Coll Med, Dept Med, Bronx, NY 10467 USAAlbert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USAUniv Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, BrazilUniv Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, BrazilWeb of ScienceFAPESPCNPqCAPESNIHFAPESP: 2016/08730-6CNPqCAPESNIH: AI52733NIH: AI1033142-21SNIH: AI124797Frontiers Media Sa2020-06-26T16:30:36Z2020-06-26T16:30:36Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion-application/pdfhttp://dx.doi.org/10.3389/fmicb.2017.01057Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017.10.3389/fmicb.2017.01057WOS000403219300001.pdf1664-302Xhttps://repositorio.unifesp.br/handle/11600/53657WOS:000403219300001engFrontiers In MicrobiologyLausanneinfo:eu-repo/semantics/openAccessSilva, Leandro B. R.Dias, Lucas S.Rittner, Glauce M. G.Munoz, Julian E.Souza, Ana C. O.Nosanchuk, Joshua D.Travassos, Luiz R. [UNIFESP]Taborda, Carlos P.reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-11T01:46:43Zoai:repositorio.unifesp.br/:11600/53657Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-11T01:46:43Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
title Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
spellingShingle Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
Silva, Leandro B. R.
Paracoccidioides brasiliensis
paracoccidioidomycosis
P10
adjuvants
dendritic cells
vaccine
title_short Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
title_full Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
title_fullStr Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
title_full_unstemmed Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
title_sort Dendritic Cells Primed with Paracoccidioides brasiliensis Peptide P10 Are Therapeutic in Immunosuppressed Mice with Paracoccidioidomycosis
author Silva, Leandro B. R.
author_facet Silva, Leandro B. R.
Dias, Lucas S.
Rittner, Glauce M. G.
Munoz, Julian E.
Souza, Ana C. O.
Nosanchuk, Joshua D.
Travassos, Luiz R. [UNIFESP]
Taborda, Carlos P.
author_role author
author2 Dias, Lucas S.
Rittner, Glauce M. G.
Munoz, Julian E.
Souza, Ana C. O.
Nosanchuk, Joshua D.
Travassos, Luiz R. [UNIFESP]
Taborda, Carlos P.
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva, Leandro B. R.
Dias, Lucas S.
Rittner, Glauce M. G.
Munoz, Julian E.
Souza, Ana C. O.
Nosanchuk, Joshua D.
Travassos, Luiz R. [UNIFESP]
Taborda, Carlos P.
dc.subject.por.fl_str_mv Paracoccidioides brasiliensis
paracoccidioidomycosis
P10
adjuvants
dendritic cells
vaccine
topic Paracoccidioides brasiliensis
paracoccidioidomycosis
P10
adjuvants
dendritic cells
vaccine
description Paracoccidioidomycosis (PCM) is an endemic systemic mycosis in Latin America, with the highest prevalence in Brazil, Colombia, and Venezuela. Fungi of the Paracoccidioides genus are etiologic agents of the disease. The 15 amino acid peptide P10 is derived from gp43, the main diagnostic antigen of Paracoccidioides brasiliensis. We previously reported that P10-pulsed dendritic cells (DCs) induce a protective response against P. brasiliensis. Presently, dexamethasone-treated BALB/c mice were intratracheally infected with P. brasiliensis Pb18 to establish the therapeutic efficacy of P10-pulsed DCs. Immunosuppressed and infected animals that received DCs had a reduction in their fungal burden, and this result was most pronounced in mice receiving DCs primed with P10. The efficacy of therapeutic DCs was significantly augmented by concomitant treatment with trimethoprim-sulfamethoxazole. Additionally, primedDCs with or without the antifungal drug induced a beneficial Th1-biased immune response and significantly reduced tissue damage. In conclusion, these studies with immunocompromised mice demonstrate that P10-pulsed DCs with or without concomitant antifungal drugs are potently effective in combating invasive PCM. These findings support further translational studies to validate the use of P10-primed DCs for PCM in immunocompetent and immunosuppressed hosts.
publishDate 2017
dc.date.none.fl_str_mv 2017
2020-06-26T16:30:36Z
2020-06-26T16:30:36Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3389/fmicb.2017.01057
Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017.
10.3389/fmicb.2017.01057
WOS000403219300001.pdf
1664-302X
https://repositorio.unifesp.br/handle/11600/53657
WOS:000403219300001
url http://dx.doi.org/10.3389/fmicb.2017.01057
https://repositorio.unifesp.br/handle/11600/53657
identifier_str_mv Frontiers In Microbiology. Lausanne, v. 8, p. -, 2017.
10.3389/fmicb.2017.01057
WOS000403219300001.pdf
1664-302X
WOS:000403219300001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Frontiers In Microbiology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv -
application/pdf
dc.coverage.none.fl_str_mv Lausanne
dc.publisher.none.fl_str_mv Frontiers Media Sa
publisher.none.fl_str_mv Frontiers Media Sa
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268344985976832